Coronavirus Disease 2019 (COVID‐19): Morocco Interrupting the Transmission by Ethics, Logistics, and Therapeutics Efforts
Soraia El Baz 1 * , Boujamâa Imziln 1
More Detail
1 Laboratory of Microbial Biotechnologies, Agrosciences and Environment (BioMAgE), Cadi Ayyad University, Faculty of Sciences Semlalia, Marrakech 40000, Morocco
* Corresponding Author

Abstract

Since the first case of 2019 novel coronavirus (COVID-19) identified on 02 March 2020 in Morocco, the number of cases rapidly increased, resulting in 3046 cases including 143 deaths as of 20 April 2020. Morocco used every possibility (socio-economic and medical) to control and to limit the spread of COVID-19 and support the implementation of social distancing measures to quickly control the outbreak. The percentage of death was 4.7% as of 20 April 2020, and increases with older age. The median age of the deaths was 65 years. Moroccan government noted that 80% of the death had health problems, 15% of positive COVID-19 cases show no symptoms and only 11.5% of patients were recovered. This report examines the impact of the ongoing pandemic of COVID-19 in Morocco. The Moroccan government has considered being more effective in responding to the pandemic. Persistent efforts have been made to limit the transmission of COVID-19, and many strategies to protect people against COVID-19 is running well to keep the spread of coronavirus under control in comparison with other countries in Europe or Africa (especially North Africa). In this report, in contrast, the situation demonstrates the need of rapid and accurate detection and identification methods that can be used in hospitals bearing the burden of identifying and treating patients. Also, this paper demonstrate that the different measures adapted by Morocco can be a good example for other developing countries and used to fight COVID-19 before it reaches the poorest countries of the world.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Brief Report

https://doi.org/10.5799/jcei/8214

J Clin Exp Invest, 2020 - Volume 11 Issue 4, Article No: em00743

Publication date: 28 Apr 2020

Article Views: 1107

Article Downloads: 354

Open Access References How to cite this article